UBS AM
VCEL icon

UBS AM’s Vericel Corp VCEL Stock Holding History

UBS AM’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Sell
83,743
-16,328
-16% -$588K ﹤0.01% 1751
2026
Q1 		$3.22M Buy
100,071
+3,738
+4% +$133K ﹤0.01% 1799
2025
Q4 		$3.47M Buy
96,333
+2,671
+3% +$98.1K ﹤0.01% 1642
2025
Q3 		$2.95M Sell
93,662
-69,288
-43% -$2.49M ﹤0.01% 1596
2025
Q2 		$6.93M Buy
162,950
+39,922
+32% +$1.66M ﹤0.01% 1534
2025
Q1 		$5.49M Buy
123,028
+10,191
+9% +$548K ﹤0.01% 1522
2024
Q4 		$6.2M Buy
112,837
+16,466
+17% +$833K ﹤0.01% 1494
2024
Q3 		$4.07M Sell
96,371
-12,375
-11% -$589K ﹤0.01% 1680
2024
Q2 		$4.99M Buy
108,746
+53,520
+97% +$2.52M ﹤0.01% 1487
2024
Q1 		$2.87M Buy
55,226
+2,624
+5% +$115K ﹤0.01% 1505
2023
Q4 		$1.87M Buy
52,602
+1,529
+3% +$53.3K ﹤0.01% 1724
2023
Q3 		$1.71M Buy
51,073
+20,317
+66% +$704K ﹤0.01% 1702
2023
Q2 		$902K Hold
30,756
– – ﹤0.01% 2055
2023
Q1 		$902K Sell
30,756
-518
-2% -$15K ﹤0.01% 2055
2022
Q4 		$824K Hold
31,274
– – ﹤0.01% 1950
2022
Q3 		$726K Hold
31,274
– – ﹤0.01% 2151
2022
Q2 		$787K Sell
31,274
-9,669
-24% -$286K ﹤0.01% 2087
2022
Q1 		$1.56M Hold
40,943
– – ﹤0.01% 1924
2021
Q4 		$1.61M Hold
40,943
– – ﹤0.01% 1974
2021
Q3 		$2M Sell
40,943
-66
-0.2% -$3.42K ﹤0.01% 1838
2021
Q2 		$2.15M Buy
41,009
+10,392
+34% +$592K ﹤0.01% 1808
2021
Q1 		$1.7M Buy
30,617
+1,138
+4% +$51.5K ﹤0.01% 1823
2020
Q4 		$910K Sell
29,479
-8,800
-23% -$209K ﹤0.01% 2039
2020
Q3 		$709K Sell
38,279
-605
-2% -$10K ﹤0.01% 1974
2020
Q2 		$537K Sell
38,884
-10,637
-21% -$144K ﹤0.01% 2098
2020
Q1 		$454K Buy
49,521
+1,036
+2% +$15.5K ﹤0.01% 2011
2019
Q4 		$844K Buy
48,485
+3,454
+8% +$58.8K ﹤0.01% 1999
2019
Q3 		$682K Buy
45,031
+6,817
+18% +$119K ﹤0.01% 2135
2019
Q2 		$722K Buy
38,214
+26,414
+224% +$450K ﹤0.01% 2039
2019
Q1 		$207K Hold
11,800
– – ﹤0.01% 2445
2018
Q4 		$205K Buy
+11,800
New +$177K ﹤0.01% 2385

Other funds holding VCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM's VCEL Position: Q2 2026 in Review

UBS AM reduced its Vericel Corp (VCEL) stake by 16% in Q2 2026, selling an estimated $588K and leaving 83,743 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

UBS AM first reported a position in VCEL in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.93M in Q2 2025. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • UBS AM held 83,743 shares of Vericel Corp worth $3.73M as of Q2 2026.
  • UBS AM sold 16,328 Vericel Corp shares in Q2 2026, an estimated $588K.
  • Vericel Corp made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1751 holding.
  • UBS AM first reported a position in Vericel Corp in Q4 2018 and has held it in 31 quarters since.
  • UBS AM's Vericel Corp position peaked at $6.93M in Q2 2025.
  • 319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.